ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 555 filers reported holding ISHARES TR in Q4 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,721 | +1.1% | 37,623 | +3.0% | 0.01% | 0.0% |
| Q2 2023 | $3,680 | -3.6% | 36,513 | -2.8% | 0.01% | -7.7% |
| Q1 2023 | $3,818 | -0.6% | 37,552 | +1.9% | 0.01% | -7.1% |
| Q4 2022 | $3,842 | -99.9% | 36,860 | +7.8% | 0.01% | +16.7% |
| Q3 2022 | $3,123,000 | -9.2% | 34,208 | -0.1% | 0.01% | 0.0% |
| Q2 2022 | $3,438,000 | -25.7% | 34,233 | -20.9% | 0.01% | -20.0% |
| Q1 2022 | $4,629,000 | +43.0% | 43,304 | +35.1% | 0.02% | +66.7% |
| Q4 2021 | $3,237,000 | +6.3% | 32,050 | -0.8% | 0.01% | -10.0% |
| Q3 2021 | $3,046,000 | -3.0% | 32,318 | -0.7% | 0.01% | +11.1% |
| Q2 2021 | $3,141,000 | +2.1% | 32,539 | +0.4% | 0.01% | 0.0% |
| Q1 2021 | $3,077,000 | +10.4% | 32,424 | +2.0% | 0.01% | 0.0% |
| Q4 2020 | $2,788,000 | +24.2% | 31,801 | +14.0% | 0.01% | -10.0% |
| Q3 2020 | $2,244,000 | -4.2% | 27,887 | -3.4% | 0.01% | -9.1% |
| Q2 2020 | $2,343,000 | -2.3% | 28,871 | -13.8% | 0.01% | -8.3% |
| Q1 2020 | $2,397,000 | -13.1% | 33,498 | +19.1% | 0.01% | +9.1% |
| Q4 2019 | $2,759,000 | +5.1% | 28,137 | +0.9% | 0.01% | -8.3% |
| Q3 2019 | $2,626,000 | +1.4% | 27,891 | +1.8% | 0.01% | +9.1% |
| Q2 2019 | $2,589,000 | +13.0% | 27,402 | +11.6% | 0.01% | 0.0% |
| Q1 2019 | $2,291,000 | +29.0% | 24,563 | +16.7% | 0.01% | +22.2% |
| Q4 2018 | $1,776,000 | -1.9% | 21,046 | +5.2% | 0.01% | +12.5% |
| Q3 2018 | $1,811,000 | +6.7% | 19,999 | +0.1% | 0.01% | +14.3% |
| Q2 2018 | $1,698,000 | +3.0% | 19,980 | +2.4% | 0.01% | 0.0% |
| Q1 2018 | $1,648,000 | -18.1% | 19,508 | -12.6% | 0.01% | -22.2% |
| Q4 2017 | $2,011,000 | +9.4% | 22,315 | +4.3% | 0.01% | 0.0% |
| Q3 2017 | $1,839,000 | +13.0% | 21,391 | +9.2% | 0.01% | +28.6% |
| Q2 2017 | $1,628,000 | +18.8% | 19,589 | +19.9% | 0.01% | +75.0% |
| Q1 2017 | $1,370,000 | +217.1% | 16,334 | +210.7% | 0.00% | +100.0% |
| Q4 2016 | $432,000 | +113.9% | 5,258 | +111.2% | 0.00% | +100.0% |
| Q3 2016 | $202,000 | -17.2% | 2,489 | -16.1% | 0.00% | 0.0% |
| Q2 2016 | $244,000 | – | 2,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $66,757,000 | 44.83% |
| Stuart Chaussee & Associates, Inc. | 243,504 | $26,028,000 | 12.40% |
| Essex Private Wealth Management, LLC | 40,860 | $4,368,000 | 11.78% |
| VAUGHAN & Co SECURITIES, INC. | 143,427 | $15,331,000 | 10.60% |
| Titus Wealth Management | 190,201 | $20,331,000 | 9.16% |
| BT Wealth Management LLC | 197,851 | $21,148,000 | 5.50% |
| Forefront Analytics, LLC | 134,961 | $14,426,000 | 5.36% |
| FOREFRONT WEALTH MANAGEMENT INC. | 47,707 | $5,099,000 | 5.04% |
| Lantz Financial LLC | 115,867 | $12,385,000 | 5.04% |
| KFA Private Wealth Group, LLC | 92,515 | $9,889,000 | 4.96% |